Mixed Growth In Latin American Pharma Markets

4 November 1996

While the largest single market in the Latin America region, Brazil, experienced growth of 24% in the 12 months to July 1996 compared with the like, year-earlier period, the next biggest markets, Argentina (down 2%) and Mexico (10% lower) did not. These figures, and the table below, are taken from the monthly and quarterly pharmaceutical audits conducted by IMS International.

All sales are shown in million of dollars at prevailing exchange rates and at price to pharmacy level. Growth figures are calculated on the basis of dollar values on a moving annual total (MAT) basis. Central America includes Costa Rica, El Salvador, Guatemala, Honduras, Nicaragua and Panama.

Country 1996 1995 US $ MAT MAT Growth ------------------------------------------ Brazil 6,868 5,530 +24 Argentina 3,601 3,673 -2 Mexico 2,541 2,810 -10 Colombia 1,079 1,082 +/- Puerto Rico 568 510 +11 Venezuela 548 529 +4 Central America 484 466 +4 Peru 447 400 +12 Chile 424 367 +16 Uruguay 257 247 +4 Ecuador 224 221 +1 Dominican Rep 165 181 -9 Paraguay 110 107 +3 Bolivia 33 35 -6 ------------------------------------------ Source: IMS International

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight